Bin Meng

2.0k total citations
62 papers, 814 citations indexed

About

Bin Meng is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Bin Meng has authored 62 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Pathology and Forensic Medicine and 14 papers in Surgery. Recurrent topics in Bin Meng's work include Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Bin Meng is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Bin Meng collaborates with scholars based in China, United States and Ethiopia. Bin Meng's co-authors include Huilai Zhang, Lanfang Li, Lihua Qiu, Shiyong Zhou, Xianhuo Wang, Xiubao Ren, Shugan Zhu, Zhengzi Qian, C. Liu and Jian Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Bin Meng

57 papers receiving 805 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bin Meng China 18 334 245 186 152 151 62 814
Magdalena Chechlińska Poland 15 370 1.1× 246 1.0× 113 0.6× 80 0.5× 122 0.8× 38 790
Ladan Fazlollahi United States 9 324 1.0× 395 1.6× 269 1.4× 112 0.7× 86 0.6× 21 1.2k
Soo Kee Min South Korea 16 309 0.9× 219 0.9× 128 0.7× 181 1.2× 170 1.1× 58 744
Dai Ikebe Japan 15 295 0.9× 252 1.0× 259 1.4× 136 0.9× 92 0.6× 26 912
Shuangping Guo China 16 188 0.6× 382 1.6× 189 1.0× 190 1.3× 197 1.3× 50 855
Hui‐Lan Rao China 20 664 2.0× 259 1.1× 218 1.2× 189 1.2× 298 2.0× 44 1.1k
Émpar Mayordomo Spain 12 428 1.3× 277 1.1× 264 1.4× 89 0.6× 112 0.7× 16 829
Kenji Yorita Japan 14 202 0.6× 260 1.1× 160 0.9× 178 1.2× 57 0.4× 72 689
Koji Koinuma Japan 20 638 1.9× 431 1.8× 296 1.6× 306 2.0× 276 1.8× 78 1.3k
Wook Youn Kim South Korea 16 403 1.2× 233 1.0× 73 0.4× 122 0.8× 354 2.3× 49 925

Countries citing papers authored by Bin Meng

Since Specialization
Citations

This map shows the geographic impact of Bin Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Meng more than expected).

Fields of papers citing papers by Bin Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Meng. The network helps show where Bin Meng may publish in the future.

Co-authorship network of co-authors of Bin Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Meng. A scholar is included among the top collaborators of Bin Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Meng. Bin Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lan, Hui Y., Bin Meng, Jianbo Li, et al.. (2025). Targeted metabolomics in PCOS mice identifies hippuric acid as a therapeutic metabolite. Steroids. 222. 109665–109665.
3.
Jiang, Zhibing, et al.. (2024). The association between statin use and diabetic nephropathy in US adults: data from NHANES 2005 - 2018. Frontiers in Endocrinology. 15. 1381746–1381746. 2 indexed citations
4.
5.
Li, Yang, Chengfeng Bi, Lanfang Li, et al.. (2023). OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma. Clinical Immunology. 251. 109637–109637. 7 indexed citations
6.
Cao, Jie, et al.. (2023). Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement. SHILAP Revista de lepidopterología. 11(8). e7780–e7780. 1 indexed citations
7.
Meng, Bin, Xiaoning Yang, Chong Shen, et al.. (2023). Significant alteration of protein profiles in a mouse model of polycystic ovary syndrome. Molecular Reproduction and Development. 91(8). e23720–e23720. 2 indexed citations
8.
Wang, Yong, Xiyin Wei, Bin Ke, et al.. (2023). Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation. Histopathology. 83(4). 631–646. 5 indexed citations
9.
10.
Wang, Xiaoxuan, Ziyi Liu, Yidan Zhang, et al.. (2022). A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma. Frontiers in Immunology. 13. 813031–813031. 12 indexed citations
11.
Wu, Jianghua, Wei Sun, Xiaodan Yang, et al.. (2021). FP07.03 Landscape Heterogeneity of PD-L1 Expression and Immune Cells Predicts Prognosis of Metastatic Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(3). S203–S204. 1 indexed citations
12.
Yu, Jingwei, Wenchen Gong, Liping Su, et al.. (2021). An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy. Frontiers in Oncology. 11. 708784–708784. 8 indexed citations
13.
Wang, Qifeng, Fen Li, Yifeng Sun, et al.. (2021). Gene Expression Profiling for Differential Diagnosis of Liver Metastases: A Multicenter, Retrospective Cohort Study. Frontiers in Oncology. 11. 725988–725988. 7 indexed citations
14.
15.
Zhang, Wenshuai, Lisha Qi, Lu Cao, et al.. (2020). ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression. Cell Death and Disease. 11(7). 511–511. 21 indexed citations
16.
Zang, Meirong, Jiaojiao Guo, Lanting Liu, et al.. (2020). Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s. Oncogenesis. 9(3). 31–31. 11 indexed citations
17.
Liu, Ning, Frank Wang, Yuhong Guo, et al.. (2020). Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 478(3). 449–458. 34 indexed citations
18.
Wang, Xianhuo, Tingting Zhang, Zheng Song, et al.. (2019). Tumor CD73/A2aR adenosine immunosuppressive axis and tumor‐infiltrating lymphocytes in diffuse large B‐cell lymphoma: correlations with clinicopathological characteristics and clinical outcome. International Journal of Cancer. 145(5). 1414–1422. 27 indexed citations
19.
Qi, Xingshun, et al.. (2010). Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: Comparison of five staging systems. European Journal of Surgical Oncology. 36(8). 718–724. 36 indexed citations
20.
Zhang, Jian, Lingyi Chi, Bin Meng, Feng Li, & Shugan Zhu. (2006). Meningioma without dural attachment: case report, classification, and review of the literature. Surgical Neurology. 67(5). 535–539. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Chechlińska Breakdown of academic impact, for papers by Ladan Fazlollahi Breakdown of academic impact, for papers by Soo Kee Min Breakdown of academic impact, for papers by Dai Ikebe Breakdown of academic impact, for papers by Shuangping Guo Breakdown of academic impact, for papers by Hui‐Lan Rao Breakdown of academic impact, for papers by Émpar Mayordomo Breakdown of academic impact, for papers by Kenji Yorita Breakdown of academic impact, for papers by Koji Koinuma Breakdown of academic impact, for papers by Wook Youn Kim
Rankless by CCL
2026